Skip to content

Teaching Physics to AI: How Aqemia Wants To Revolutionize Drug Discovery

Aqemia's Novel Approach to Drug Discovery Attracts €30M in New Funding

Aqemia co-founders: Emmanuelle Martiano-Rolland (COO) & Maximilien Levesque (CEO)

This post is for paying subscribers only

Subscribe

Already have an account? Sign In

Latest

H CEO Charles Kantor takes the stage at the ai-Pulse conference in November 2024. Photo courtesy of Scaleway.
AI

H Company Launches Autonomous Agent Suite To Leapfrog Tech Giants

The French AI startup, backed by top investors, released a suite of cost-efficient autonomous agents that it claims outperform OpenAI, Anthropic, and Google. Designed to execute real-world tasks, these "action models" signal a shift from chatbots to true AI-powered productivity.

Members Public